Latest News and Press Releases

George Medicines signs exclusive licensing agreement with Azurity Pharmaceuticals to commercialize WIDAPLIK™ (telmisartan, amlodipine and indapamide) tablets in the US An innovative single pill...

Novel, single pill, triple combination with a standard dose and two lower doses that can deliver the efficacy benefits of combination therapy, with an established safety profile and good...

Therapy dogs are traveling the halls of Alameda Health System's hospitals, providing comfort to patients and staff alike.

George Medicines appoints Amy Carroll as Senior Vice President of Medical Affairs London, UK, 3 February 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing...

George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Colombia and Central AmericaBausch Health gains exclusive rights to single-pill triple...

New York, USA, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Market Overview The market for blood pressure cuffs is poised to exhibit a robust CAGR of 8.9% from 2025 to 2034. The blood pressure cuffs market...

Phase III trial results of novel triple combination pill for hypertension published in The Lancet Novel combination pill significantly reduced blood pressure and improved control rates vs dual...

Wilmington, Delaware, United States, Transparency Market Research Inc. - , July 04, 2024 (GLOBE NEWSWIRE) -- The kidney transplant market was projected to attain US$ 81.0 billion in 2023. It is...

Wilmington, Delaware, United States, March 04, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global blood pressure cuffs market is projected to rise at a CAGR of 6.5% from 2023 to...

OAKBROOK TERRACE, Illinois, June 15, 2023 (GLOBE NEWSWIRE) -- Asymptomatic severe hypertension, also known as hypertensive urgency, is severely elevated blood pressure (BP) that is frequently...